Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax Consolidation in CLL Patients on BTK Inhibitors
NCT06958705Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in chronic lymphocytic leukemia (CLL), sponsored by Jiangsu Provincial People's Hospital. Started Dec 2025; status: recruiting.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT06958705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06958705.